Integrated BioPharma, Inc.
INBP · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $14,175 | $13,947 | $12,614 |
| % Growth | -100% | 1.6% | 10.6% | – |
| Cost of Goods Sold | $0 | $12,706 | $12,396 | $11,443 |
| Gross Profit | $1,019 | $1,469 | $1,551 | $1,171 |
| % Margin | – | 10.4% | 11.1% | 9.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $856 | $880 | $812 | $969 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $856 | $880 | $812 | $969 |
| Operating Income | $163 | $589 | $739 | $202 |
| % Margin | – | 4.2% | 5.3% | 1.6% |
| Other Income/Exp. Net | $33 | $6 | $39 | -$17 |
| Pre-Tax Income | $196 | $595 | $778 | $185 |
| Tax Expense | $73 | $773 | $167 | $69 |
| Net Income | $123 | -$178 | $611 | $116 |
| % Margin | – | -1.3% | 4.4% | 0.9% |
| EPS | 0.004 | -0.006 | 0.02 | 0.004 |
| % Growth | 169% | -128.7% | 431.6% | – |
| EPS Diluted | 0.004 | -0.006 | 0.019 | 0.004 |
| Weighted Avg Shares Out | 31,060 | 30,622 | 30,301 | 30,175 |
| Weighted Avg Shares Out Dil | 31,421 | 30,622 | 31,515 | 31,303 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $9 | $5 | $11 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $250 | $327 | $304 | $318 |
| EBITDA | $446 | $922 | $1,043 | $520 |
| % Margin | – | 6.5% | 7.5% | 4.1% |